Cutaneous sarcoidosis: clinico-epidemiological profile of 72 patients at a tertiary hospital in Sao Paulo, Brazil

被引:3
作者
Torquato, Mariana Fernandes [1 ]
Souza da Costa, Marcella Karen [1 ]
Simonsen Nico, Marcello Menta [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Dermatol Dept, Sao Paulo, SP, Brazil
关键词
Brazil; Epidemiology; Granulomatous disease; chronic; Sarcoidosis; Skin manifestations; INVOLVEMENT; LESIONS; MANIFESTATIONS; SERIES;
D O I
10.1016/j.abd.2019.06.004
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Sarcoidosis is a multisystem disease of unknown cause that is characterized by the presence of granulomas in various organs. Cutaneous involvement is common and the reported incidence has varied from 9% to 37%. Studies on cutaneous sarcoidosis in Brazil are lacking. Objectives: To describe the clinical and epidemiological aspects of patients with cutaneous sarcoidosis diagnosed at the Department of Dermatology of the University of Sao Paulo, from May 1994 to March 2018. Methods: Clinical data of patients with confirmed cutaneous sarcoidosis were retrospectively reviewed and classified according to gender, ethnicity, age at diagnosis, cutaneous presentation, systemic involvement and treatment. Results: Cutaneous sarcoidosis was diagnosed in 72 patients with a female predominance (74%). The mean age at diagnosis was 49.6 years and most of the patients were white (61%). Papules and plaques were the most common lesions. Systemic sarcoidosis was detected in 81% of patients, affecting mainly the lungs and thoracic lymph nodes (97%). Typically, cutaneous lesions were the first manifestation (74%). Systemic therapy was necessary for 72% of patients; the dermatologist managed many of these cases. Oral glucocorticoids were the most commonly used systemic medication (92%). The mean number of systemic drugs used was 1.98 per patient. Limitations: Insufficient data in medical records. Conclusions: This series highlights the dermatologist role in recognizing and diagnosing cutaneous sarcoidosis, evaluating patients for systemic disease involvement and treating the skin manifestations. Cutaneous sarcoidosis was once considered exceedingly infrequent in Brazil in comparison to infectious granulomatous diseases; however, the present series seems to suggest that the disease is not so rare in this region. (C) 2019 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 24 条
[1]  
[Anonymous], 1999, Am J Respir Crit Care Med, V160, P736
[2]  
Baughman RP, 2005, EVIDENCE-BASED RESPIRATORY MEDICINE, P491, DOI 10.1002/9780470987377.ch37
[3]  
Bethlem N., 1985, SARCOIDOSIS, V2
[4]  
Elgart M L, 1986, Clin Dermatol, V4, P35, DOI 10.1016/0738-081X(86)90032-5
[5]  
Elgart M L, 1978, Prim Care, V5, P249
[6]  
Haimovic A, 2012, J AM ACAD DERMATOL, V66, DOI 10.1016/j.jaad.2011.11.965
[7]   Cutaneous sarcoidosis: clinicopathologic study of 76 patients from Lebanon [J].
Ishak, Rim ;
Kurban, Mazen ;
Kibbi, Abdul-Ghani ;
Abbas, Ossama .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (01) :33-41
[8]   Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial [J].
Judson, M. A. ;
Baughman, R. P. ;
Costabel, U. ;
Flavin, S. ;
Lo, K. H. ;
Kavuru, M. S. ;
Drent, M. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) :1189-1196
[9]   The diagnosis of sarcoidosis [J].
Judson, Marc A. .
CLINICS IN CHEST MEDICINE, 2008, 29 (03) :415-+
[10]   Cutaneous sarcoidosis A retrospective case series and a hospital-based case-control study in Taiwan [J].
Liu, Kwei-Lan ;
Tsai, Wen-Chien ;
Lee, Chih-Hung .
MEDICINE, 2017, 96 (40)